The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow.
AuthorsTurner, S D
Rafferty, Joseph A
Fairbairn, Leslie J
Eckert, H G
Lashford, Linda S
AffiliationDepartment of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractWe have used the bone marrow micronucleus assay (BMMN) as a measure of clastogenicity, in response to etoposide exposure in murine bone marrow. Oral delivery of etoposide resulted in a reduced number of micronucleated polychromatic erythrocytes (MPE) relative to the same dose delivered intraperitoneally (P < 0.001). Daily fractionation of the oral schedule of etoposide led to a more than six-fold increase in cumulative MPE frequency over that observed with the same total, unfractionated dose, with the potency of the response increasing with serial exposure (r = 0.79). Retrovirally-mediated expression of MDR1 in murine bone marrow resulted in partial protection against the clastogenic activity of etoposide relative to mock transduced control mice. The model system developed has indicated a variety of factors able to influence the genotoxicity of etoposide. It should now be possible to further exploit this model in order to define other factors governing haemopoietic sensitivity to etoposide.
CitationThe effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow. 2000, 14 (10):1796-802 Leukemia
- Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses.
- Authors: Ashby J, Tinwell H, Glover P, Poorman-Allen P, Krehl R, Callander RD, Clive D
- Issue date: 1994
- The dual effect of curcumin on etoposide action in leukemic and healthy bone marrow cells of rats with acute myeloid leukemia.
- Authors: Papiez MA, Krzyściak W
- Issue date: 2014
- Cytogenetic risk assessment of etoposide from mouse bone marrow.
- Authors: Choudhury RC, Palo AK, Sahu P
- Issue date: 2004 Mar-Apr
- Comparison of single/multiple-dose protocols using triethylenemelamine and procarbazine hydrochloride for the mouse bone marrow micronucleus test.
- Authors: Romagna F, Schneider BM
- Issue date: 1990 Jun-Aug
- The skeletal impact of the chemotherapeutic agent etoposide.
- Authors: Koh AJ, Sinder BP, Entezami P, Nilsson L, McCauley LK
- Issue date: 2017 Aug